Trial Profile
PERICLES (PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study)-a Phase 2 Study of Atezolizumab With or Without Radiotherapy in Penile Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2023
Price :
$35
*
At a glance
- Drugs Atezolizumab (Primary)
- Indications Penile cancer; Squamous cell cancer; Urethral cancer
- Focus Therapeutic Use
- Acronyms PERICLES
- 24 Jul 2023 Results assessing safety and efficacy of Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis published in the Journal of Clinical Oncology
- 09 May 2023 Planned End Date changed from 1 Dec 2023 to 15 Sep 2023.
- 09 May 2023 Planned primary completion date changed from 1 Apr 2023 to 15 Aug 2023.